President Biden first signaled his intent to require many American workers to obtain full vaccination against COVID-19 in September. Now, a significant number of employers must ensure their workers are either vaccinated or tested weekly for COVID-19 by January 4 as the rules become official. The requirements will apply to employers with at least 100…
Pfizer projects $36 billion in COVID-19 vaccine revenue in 2021
Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) continue to dominate the COVID-19 vaccine market. In 2021, Pfizer anticipates that the Comirnaty (BNT162b2) vaccine will generate $36 billion in sales. For the sake of comparison, the company’s overall 2020 revenue was $41.9 billion. The vaccine was the single biggest driver of revenue for the company in…
CDC authorizes fourth COVID-19 vaccine dose for some immunocompromised patients
As a growing number of Americans become eligible for a third dose of COVID-19 vaccines, CDC continues to expand its booster guidelines. The agency has amended its criteria for moderately to severely immunocompromised people to allow a fourth dose of COVID-19 vaccine six months after receiving the third dose. The criteria pertain to immunocompromised individuals…
White House envisions $65 billion plan to battle future pandemics
With President Biden’s popularity recently slipping to a new low, the White House has announced a sweeping plan to blunt the impact of future pandemics. In the proposal titled “American Pandemic Preparedness: Transforming Our Capabilities,” the White House argues that “critical work” is “needed to transform U.S. capabilities to respond rapidly and effectively to any…
Drug prescription volume growth climbed to 21% in late May
As the U.S. economy continues to stabilize in the wake of the COVID-19 pandemic, prescription volumes continue to rebound as well. The overall market growth for prescription drugs from May 21–28 hit 21% year over year, according to IQVIA data. The growth rate in the prior two weeks was 13%. New prescription growth from May…
The top 5 pharma firms by reputation
Recent research from reputation data specialist RepTrak (Boston) indicates that the pharma industry had the largest year-over-year reputational improvement of any sector, according to its roundup of top 100 corporations. The sector saw significant gains in consumers’ perception of its citizenship and governance. Now ranked eighth overall, the pharma industry came in just ahead of…
It’s time to rethink pharma supply chains
Global supply chains have arguably seen more disruption in the past year than they have seen in decades. Pharmaceutical supply chains were especially vulnerable in the early days of the COVID-19 pandemic, prompting a rethink of supply chain management for the industry. Another wrinkle is a recent executive order from President Biden, which prompted a…